Anthony P Conley Selected Research

Paraffin

1/2020

The immune microenvironment of uterine adenosarcomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony P Conley Research Topics

Disease

35	Neoplasms (Cancer) 05/2024 - 09/2015
23	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 07/2008
6	Liposarcoma 02/2024 - 01/2013
5	Leiomyosarcoma 04/2024 - 01/2013
5	Synovial Sarcoma (Synovioma) 01/2022 - 01/2013
5	Melanoma (Melanoma, Malignant) 05/2019 - 12/2012
4	Chordoma 05/2024 - 01/2022
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2024 - 02/2011
3	Alveolar Soft Part Sarcoma 09/2023 - 01/2020
3	Chondrosarcoma 01/2023 - 01/2019
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2013
2	Neoplasm Metastasis (Metastasis) 05/2024 - 12/2012
2	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2018
2	Triple Negative Breast Neoplasms 01/2024 - 01/2023
2	Hemangiosarcoma (Angiosarcoma) 01/2022 - 01/2022
2	Neurofibrosarcoma (MPNST) 10/2021 - 01/2013
2	Testicular Neoplasms (Testicular Cancer) 05/2019 - 01/2017
2	Ewing Sarcoma (Sarcoma, Ewing) 10/2017 - 01/2013
1	Cholangiocarcinoma 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Body Weight (Weight, Body) 09/2023
1	Nausea 01/2023
1	Anemia 01/2023
1	Fatigue 01/2023
1	Leukopenia 01/2023
1	Neutropenia 01/2023
1	Rectal Neoplasms (Rectal Cancer) 09/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Disease Progression 01/2022
1	Colitis 01/2022
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2021
1	Coccidioidomycosis 01/2021
1	Necrosis 01/2020
1	Mobility Limitation (Difficulty Walking) 11/2019
1	Paresthesia (Dysesthesia) 11/2019
1	Hypesthesia (Numbness) 11/2019
1	Guillain-Barre Syndrome 11/2019
1	Carcinogenesis 08/2019
1	Mesenchymal Chondrosarcoma 01/2019

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2008
3	AntigensIBA 10/2021 - 01/2017
3	Ifosfamide FDA LinkGeneric 04/2021 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2017
2	NivolumabIBA 02/2024 - 01/2022
2	GenieIBA 11/2023 - 08/2019
2	Gemcitabine FDA Link 01/2023 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 11/2019
2	CytokinesIBA 01/2018 - 01/2018
1	monooxyethylene trimethylolpropane tristearate (MTTS)IBA 05/2024
1	ErbB Receptors (EGF Receptor)IBA 05/2024
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2024
1	Ribonucleases (Ribonuclease)IBA 04/2024
1	ripretinibIBA 02/2024
1	avapritinibIBA 02/2024
1	IpilimumabIBA 02/2024
1	Janus Kinase 1IBA 01/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024
1	Hormones (Hormone)IBA 01/2024
1	Phosphotransferases (Kinase)IBA 01/2024
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2024
1	atezolizumabIBA 09/2023
1	eribulin FDA Link 01/2023
1	selinexorIBA 01/2023
1	Exportin 1 ProteinIBA 01/2023
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2023
1	dostarlimabIBA 09/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	durvalumabIBA 01/2022
1	tremelimumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	bempegaldesleukinIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 10/2021
1	Fluconazole (Zonal)FDA LinkGeneric 01/2021
1	alovudineIBA 02/2020
1	Transcription Factor 3IBA 01/2020
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2020
1	entrectinibIBA 01/2020
1	ParaffinIBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 08/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	CreatinineIBA 01/2019
1	VemurafenibIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019

Therapy/Procedure

27	Therapeutics 05/2024 - 01/2013
9	Drug Therapy (Chemotherapy) 01/2023 - 03/2012
7	Immunotherapy 01/2022 - 03/2012
3	Radiotherapy 05/2024 - 05/2022
2	Molecular Targeted Therapy 05/2024 - 01/2020
2	Neoadjuvant Therapy 02/2024 - 02/2020
2	Investigational Therapies (Experimental Therapy) 01/2023 - 01/2020
1	Combined Modality Therapy 10/2019